nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Nystagmus—Vinblastine—germ cell cancer	0.0226	0.0226	CcSEcCtD
Glycopyrrolate—Aggression—Bleomycin—germ cell cancer	0.0155	0.0155	CcSEcCtD
Glycopyrrolate—Ventricular fibrillation—Ifosfamide—germ cell cancer	0.0152	0.0152	CcSEcCtD
Glycopyrrolate—Photophobia—Vinblastine—germ cell cancer	0.0151	0.0151	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Bleomycin—germ cell cancer	0.0133	0.0133	CcSEcCtD
Glycopyrrolate—Cystitis—Bleomycin—germ cell cancer	0.0131	0.0131	CcSEcCtD
Glycopyrrolate—Ageusia—Cisplatin—germ cell cancer	0.0124	0.0124	CcSEcCtD
Glycopyrrolate—Bladder pain—Bleomycin—germ cell cancer	0.0123	0.0123	CcSEcCtD
Glycopyrrolate—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.0116	0.0116	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Ifosfamide—germ cell cancer	0.00891	0.00891	CcSEcCtD
Glycopyrrolate—Pain in extremity—Ifosfamide—germ cell cancer	0.00845	0.00845	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Vinblastine—germ cell cancer	0.00805	0.00805	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Ifosfamide—germ cell cancer	0.00803	0.00803	CcSEcCtD
Glycopyrrolate—Urinary retention—Ifosfamide—germ cell cancer	0.00803	0.00803	CcSEcCtD
Glycopyrrolate—Nasal congestion—Cisplatin—germ cell cancer	0.00799	0.00799	CcSEcCtD
Glycopyrrolate—Pneumonia—Bleomycin—germ cell cancer	0.00766	0.00766	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00752	0.00752	CcSEcCtD
Glycopyrrolate—Pneumonia—Dactinomycin—germ cell cancer	0.00714	0.00714	CcSEcCtD
Glycopyrrolate—Irritability—Cisplatin—germ cell cancer	0.00695	0.00695	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00689	0.00689	CcSEcCtD
Glycopyrrolate—Dysuria—Ifosfamide—germ cell cancer	0.00683	0.00683	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Bleomycin—germ cell cancer	0.0068	0.0068	CcSEcCtD
Glycopyrrolate—Dehydration—Cisplatin—germ cell cancer	0.00677	0.00677	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00659	0.00659	CcSEcCtD
Glycopyrrolate—Pneumonia—Ifosfamide—germ cell cancer	0.00655	0.00655	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Cisplatin—germ cell cancer	0.00651	0.00651	CcSEcCtD
Glycopyrrolate—Infestation—Ifosfamide—germ cell cancer	0.00651	0.00651	CcSEcCtD
Glycopyrrolate—Infestation NOS—Ifosfamide—germ cell cancer	0.00651	0.00651	CcSEcCtD
Glycopyrrolate—Flushing—Bleomycin—germ cell cancer	0.00635	0.00635	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Etoposide—germ cell cancer	0.00634	0.00634	CcSEcCtD
Glycopyrrolate—Convulsion—Vinblastine—germ cell cancer	0.00611	0.00611	CcSEcCtD
Glycopyrrolate—Hypertension—Vinblastine—germ cell cancer	0.00608	0.00608	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Cisplatin—germ cell cancer	0.00603	0.00603	CcSEcCtD
Glycopyrrolate—Erythema—Bleomycin—germ cell cancer	0.00595	0.00595	CcSEcCtD
Glycopyrrolate—Flushing—Dactinomycin—germ cell cancer	0.00592	0.00592	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00577	0.00577	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00574	0.00574	CcSEcCtD
Glycopyrrolate—Urethral disorder—Ifosfamide—germ cell cancer	0.00573	0.00573	CcSEcCtD
Glycopyrrolate—Erythema—Dactinomycin—germ cell cancer	0.00555	0.00555	CcSEcCtD
Glycopyrrolate—Flushing—Ifosfamide—germ cell cancer	0.00542	0.00542	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Ifosfamide—germ cell cancer	0.00542	0.00542	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Methotrexate—germ cell cancer	0.00538	0.00538	CcSEcCtD
Glycopyrrolate—Cystitis—Methotrexate—germ cell cancer	0.00532	0.00532	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00527	0.00527	CcSEcCtD
Glycopyrrolate—Pneumonia—Etoposide—germ cell cancer	0.00517	0.00517	CcSEcCtD
Glycopyrrolate—Infestation NOS—Etoposide—germ cell cancer	0.00514	0.00514	CcSEcCtD
Glycopyrrolate—Infestation—Etoposide—germ cell cancer	0.00514	0.00514	CcSEcCtD
Glycopyrrolate—Mental disorder—Ifosfamide—germ cell cancer	0.00512	0.00512	CcSEcCtD
Glycopyrrolate—Erythema—Ifosfamide—germ cell cancer	0.00509	0.00509	CcSEcCtD
Glycopyrrolate—Malnutrition—Ifosfamide—germ cell cancer	0.00509	0.00509	CcSEcCtD
Glycopyrrolate—Bladder pain—Methotrexate—germ cell cancer	0.00498	0.00498	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Cisplatin—germ cell cancer	0.00497	0.00497	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Cisplatin—germ cell cancer	0.00495	0.00495	CcSEcCtD
Glycopyrrolate—Urethral disorder—Cisplatin—germ cell cancer	0.00494	0.00494	CcSEcCtD
Glycopyrrolate—Constipation—Vinblastine—germ cell cancer	0.00492	0.00492	CcSEcCtD
Glycopyrrolate—Pain—Vinblastine—germ cell cancer	0.00492	0.00492	CcSEcCtD
Glycopyrrolate—Confusional state—Bleomycin—germ cell cancer	0.0049	0.0049	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Bleomycin—germ cell cancer	0.00486	0.00486	CcSEcCtD
Glycopyrrolate—Oedema—Bleomycin—germ cell cancer	0.00486	0.00486	CcSEcCtD
Glycopyrrolate—Infection—Bleomycin—germ cell cancer	0.00483	0.00483	CcSEcCtD
Glycopyrrolate—Vision blurred—Ifosfamide—germ cell cancer	0.00479	0.00479	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Vinblastine—germ cell cancer	0.00474	0.00474	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Vinblastine—germ cell cancer	0.0047	0.0047	CcSEcCtD
Glycopyrrolate—Flushing—Cisplatin—germ cell cancer	0.00468	0.00468	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Cisplatin—germ cell cancer	0.00468	0.00468	CcSEcCtD
Glycopyrrolate—Agitation—Ifosfamide—germ cell cancer	0.00467	0.00467	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Etoposide—germ cell cancer	0.00459	0.00459	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Etoposide—germ cell cancer	0.00456	0.00456	CcSEcCtD
Glycopyrrolate—Abdominal pain—Vinblastine—germ cell cancer	0.00455	0.00455	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Cisplatin—germ cell cancer	0.00454	0.00454	CcSEcCtD
Glycopyrrolate—Hypotension—Bleomycin—germ cell cancer	0.00454	0.00454	CcSEcCtD
Glycopyrrolate—Oedema—Dactinomycin—germ cell cancer	0.00453	0.00453	CcSEcCtD
Glycopyrrolate—Urethral disorder—Etoposide—germ cell cancer	0.00452	0.00452	CcSEcCtD
Glycopyrrolate—Infection—Dactinomycin—germ cell cancer	0.0045	0.0045	CcSEcCtD
Glycopyrrolate—Palpitations—Ifosfamide—germ cell cancer	0.0045	0.0045	CcSEcCtD
Glycopyrrolate—Convulsion—Ifosfamide—germ cell cancer	0.00441	0.00441	CcSEcCtD
Glycopyrrolate—Hypertension—Ifosfamide—germ cell cancer	0.00439	0.00439	CcSEcCtD
Glycopyrrolate—Malnutrition—Cisplatin—germ cell cancer	0.00439	0.00439	CcSEcCtD
Glycopyrrolate—Erythema—Cisplatin—germ cell cancer	0.00439	0.00439	CcSEcCtD
Glycopyrrolate—Flatulence—Cisplatin—germ cell cancer	0.00432	0.00432	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.0043	0.0043	CcSEcCtD
Glycopyrrolate—Flushing—Etoposide—germ cell cancer	0.00428	0.00428	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Etoposide—germ cell cancer	0.00428	0.00428	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Vinblastine—germ cell cancer	0.00424	0.00424	CcSEcCtD
Glycopyrrolate—Confusional state—Ifosfamide—germ cell cancer	0.00419	0.00419	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Etoposide—germ cell cancer	0.00416	0.00416	CcSEcCtD
Glycopyrrolate—Pain—Bleomycin—germ cell cancer	0.00415	0.00415	CcSEcCtD
Glycopyrrolate—Oedema—Ifosfamide—germ cell cancer	0.00415	0.00415	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00415	0.00415	CcSEcCtD
Glycopyrrolate—Vision blurred—Cisplatin—germ cell cancer	0.00413	0.00413	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00413	0.00413	CcSEcCtD
Glycopyrrolate—Asthenia—Vinblastine—germ cell cancer	0.00413	0.00413	CcSEcCtD
Glycopyrrolate—Infection—Ifosfamide—germ cell cancer	0.00412	0.00412	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Ifosfamide—germ cell cancer	0.00407	0.00407	CcSEcCtD
Glycopyrrolate—Skin disorder—Ifosfamide—germ cell cancer	0.00403	0.00403	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00401	0.00401	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Bleomycin—germ cell cancer	0.004	0.004	CcSEcCtD
Glycopyrrolate—Dysgeusia—Etoposide—germ cell cancer	0.00393	0.00393	CcSEcCtD
Glycopyrrolate—Fatigue—Dactinomycin—germ cell cancer	0.00391	0.00391	CcSEcCtD
Glycopyrrolate—Hypotension—Ifosfamide—germ cell cancer	0.00388	0.00388	CcSEcCtD
Glycopyrrolate—Pain—Dactinomycin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Glycopyrrolate—Urticaria—Bleomycin—germ cell cancer	0.00386	0.00386	CcSEcCtD
Glycopyrrolate—Body temperature increased—Bleomycin—germ cell cancer	0.00384	0.00384	CcSEcCtD
Glycopyrrolate—Irritability—Methotrexate—germ cell cancer	0.00381	0.00381	CcSEcCtD
Glycopyrrolate—Dizziness—Vinblastine—germ cell cancer	0.0038	0.0038	CcSEcCtD
Glycopyrrolate—Convulsion—Cisplatin—germ cell cancer	0.0038	0.0038	CcSEcCtD
Glycopyrrolate—Mood swings—Methotrexate—germ cell cancer	0.00379	0.00379	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dactinomycin—germ cell cancer	0.00373	0.00373	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00371	0.00371	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.0037	0.0037	CcSEcCtD
Glycopyrrolate—Somnolence—Ifosfamide—germ cell cancer	0.00369	0.00369	CcSEcCtD
Glycopyrrolate—Vomiting—Vinblastine—germ cell cancer	0.00366	0.00366	CcSEcCtD
Glycopyrrolate—Headache—Vinblastine—germ cell cancer	0.0036	0.0036	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dactinomycin—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dactinomycin—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Fatigue—Ifosfamide—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Cisplatin—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Oedema—Cisplatin—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Bleomycin—germ cell cancer	0.00358	0.00358	CcSEcCtD
Glycopyrrolate—Infection—Cisplatin—germ cell cancer	0.00356	0.00356	CcSEcCtD
Glycopyrrolate—Pain—Ifosfamide—germ cell cancer	0.00355	0.00355	CcSEcCtD
Glycopyrrolate—Constipation—Ifosfamide—germ cell cancer	0.00355	0.00355	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Cisplatin—germ cell cancer	0.00351	0.00351	CcSEcCtD
Glycopyrrolate—Tachycardia—Cisplatin—germ cell cancer	0.00349	0.00349	CcSEcCtD
Glycopyrrolate—Asthenia—Bleomycin—germ cell cancer	0.00349	0.00349	CcSEcCtD
Glycopyrrolate—Convulsion—Etoposide—germ cell cancer	0.00348	0.00348	CcSEcCtD
Glycopyrrolate—Skin disorder—Cisplatin—germ cell cancer	0.00348	0.00348	CcSEcCtD
Glycopyrrolate—Hypertension—Etoposide—germ cell cancer	0.00347	0.00347	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Cisplatin—germ cell cancer	0.00346	0.00346	CcSEcCtD
Glycopyrrolate—Pruritus—Bleomycin—germ cell cancer	0.00344	0.00344	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ifosfamide—germ cell cancer	0.00342	0.00342	CcSEcCtD
Glycopyrrolate—Nausea—Vinblastine—germ cell cancer	0.00342	0.00342	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0034	0.0034	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00339	0.00339	CcSEcCtD
Glycopyrrolate—Hypotension—Cisplatin—germ cell cancer	0.00334	0.00334	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Dactinomycin—germ cell cancer	0.00334	0.00334	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—germ cell cancer	0.00331	0.00331	CcSEcCtD
Glycopyrrolate—Confusional state—Etoposide—germ cell cancer	0.00331	0.00331	CcSEcCtD
Glycopyrrolate—Urticaria—Ifosfamide—germ cell cancer	0.0033	0.0033	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ifosfamide—germ cell cancer	0.00328	0.00328	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ifosfamide—germ cell cancer	0.00328	0.00328	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Etoposide—germ cell cancer	0.00328	0.00328	CcSEcCtD
Glycopyrrolate—Infection—Etoposide—germ cell cancer	0.00326	0.00326	CcSEcCtD
Glycopyrrolate—Asthenia—Dactinomycin—germ cell cancer	0.00325	0.00325	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—germ cell cancer	0.00323	0.00323	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00321	0.00321	CcSEcCtD
Glycopyrrolate—Tachycardia—Etoposide—germ cell cancer	0.0032	0.0032	CcSEcCtD
Glycopyrrolate—Skin disorder—Etoposide—germ cell cancer	0.00318	0.00318	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—germ cell cancer	0.00318	0.00318	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Etoposide—germ cell cancer	0.00317	0.00317	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—germ cell cancer	0.0031	0.0031	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00309	0.00309	CcSEcCtD
Glycopyrrolate—Vomiting—Bleomycin—germ cell cancer	0.00309	0.00309	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—germ cell cancer	0.00308	0.00308	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—germ cell cancer	0.00308	0.00308	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—germ cell cancer	0.00308	0.00308	CcSEcCtD
Glycopyrrolate—Hypotension—Etoposide—germ cell cancer	0.00306	0.00306	CcSEcCtD
Glycopyrrolate—Rash—Bleomycin—germ cell cancer	0.00306	0.00306	CcSEcCtD
Glycopyrrolate—Pain—Cisplatin—germ cell cancer	0.00306	0.00306	CcSEcCtD
Glycopyrrolate—Dermatitis—Bleomycin—germ cell cancer	0.00306	0.00306	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ifosfamide—germ cell cancer	0.00306	0.00306	CcSEcCtD
Glycopyrrolate—Asthenia—Ifosfamide—germ cell cancer	0.00298	0.00298	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—germ cell cancer	0.00295	0.00295	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Cisplatin—germ cell cancer	0.00295	0.00295	CcSEcCtD
Glycopyrrolate—Pruritus—Ifosfamide—germ cell cancer	0.00294	0.00294	CcSEcCtD
Glycopyrrolate—Somnolence—Etoposide—germ cell cancer	0.00291	0.00291	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—germ cell cancer	0.0029	0.0029	CcSEcCtD
Glycopyrrolate—Nausea—Bleomycin—germ cell cancer	0.00289	0.00289	CcSEcCtD
Glycopyrrolate—Vomiting—Dactinomycin—germ cell cancer	0.00288	0.00288	CcSEcCtD
Glycopyrrolate—Rash—Dactinomycin—germ cell cancer	0.00286	0.00286	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Body temperature increased—Cisplatin—germ cell cancer	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Fatigue—Etoposide—germ cell cancer	0.00283	0.00283	CcSEcCtD
Glycopyrrolate—Pain—Etoposide—germ cell cancer	0.0028	0.0028	CcSEcCtD
Glycopyrrolate—Constipation—Etoposide—germ cell cancer	0.0028	0.0028	CcSEcCtD
Glycopyrrolate—Dizziness—Ifosfamide—germ cell cancer	0.00275	0.00275	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—germ cell cancer	0.00273	0.00273	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—germ cell cancer	0.00271	0.00271	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Etoposide—germ cell cancer	0.0027	0.0027	CcSEcCtD
Glycopyrrolate—Nausea—Dactinomycin—germ cell cancer	0.00269	0.00269	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Etoposide—germ cell cancer	0.00268	0.00268	CcSEcCtD
Glycopyrrolate—Vomiting—Ifosfamide—germ cell cancer	0.00264	0.00264	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Cisplatin—germ cell cancer	0.00264	0.00264	CcSEcCtD
Glycopyrrolate—Rash—Ifosfamide—germ cell cancer	0.00262	0.00262	CcSEcCtD
Glycopyrrolate—Dermatitis—Ifosfamide—germ cell cancer	0.00262	0.00262	CcSEcCtD
Glycopyrrolate—Urticaria—Etoposide—germ cell cancer	0.0026	0.0026	CcSEcCtD
Glycopyrrolate—Abdominal pain—Etoposide—germ cell cancer	0.00259	0.00259	CcSEcCtD
Glycopyrrolate—Body temperature increased—Etoposide—germ cell cancer	0.00259	0.00259	CcSEcCtD
Glycopyrrolate—Asthenia—Cisplatin—germ cell cancer	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—germ cell cancer	0.00257	0.00257	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—germ cell cancer	0.00249	0.00249	CcSEcCtD
Glycopyrrolate—Nausea—Ifosfamide—germ cell cancer	0.00247	0.00247	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—germ cell cancer	0.00242	0.00242	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Etoposide—germ cell cancer	0.00242	0.00242	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—germ cell cancer	0.00241	0.00241	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—germ cell cancer	0.00241	0.00241	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—germ cell cancer	0.00236	0.00236	CcSEcCtD
Glycopyrrolate—Asthenia—Etoposide—germ cell cancer	0.00235	0.00235	CcSEcCtD
Glycopyrrolate—Pruritus—Etoposide—germ cell cancer	0.00232	0.00232	CcSEcCtD
Glycopyrrolate—Vomiting—Cisplatin—germ cell cancer	0.00228	0.00228	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—germ cell cancer	0.00227	0.00227	CcSEcCtD
Glycopyrrolate—Rash—Cisplatin—germ cell cancer	0.00226	0.00226	CcSEcCtD
Glycopyrrolate—Dermatitis—Cisplatin—germ cell cancer	0.00225	0.00225	CcSEcCtD
Glycopyrrolate—Dizziness—Etoposide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Glycopyrrolate—Nausea—Cisplatin—germ cell cancer	0.00213	0.00213	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—germ cell cancer	0.00209	0.00209	CcSEcCtD
Glycopyrrolate—Vomiting—Etoposide—germ cell cancer	0.00208	0.00208	CcSEcCtD
Glycopyrrolate—Rash—Etoposide—germ cell cancer	0.00207	0.00207	CcSEcCtD
Glycopyrrolate—Dermatitis—Etoposide—germ cell cancer	0.00207	0.00207	CcSEcCtD
Glycopyrrolate—Headache—Etoposide—germ cell cancer	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—germ cell cancer	0.00198	0.00198	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—germ cell cancer	0.00196	0.00196	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—germ cell cancer	0.00195	0.00195	CcSEcCtD
Glycopyrrolate—Nausea—Etoposide—germ cell cancer	0.00195	0.00195	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—germ cell cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—germ cell cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—germ cell cancer	0.0019	0.0019	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—germ cell cancer	0.00184	0.00184	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—germ cell cancer	0.00178	0.00178	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—germ cell cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—germ cell cancer	0.00173	0.00173	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—germ cell cancer	0.00169	0.00169	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—germ cell cancer	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—germ cell cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00161	0.00161	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—germ cell cancer	0.00156	0.00156	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—germ cell cancer	0.00155	0.00155	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—germ cell cancer	0.00155	0.00155	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—germ cell cancer	0.00145	0.00145	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—germ cell cancer	0.00139	0.00139	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—germ cell cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—germ cell cancer	0.00125	0.00125	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—germ cell cancer	0.00124	0.00124	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—germ cell cancer	0.00124	0.00124	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—germ cell cancer	0.00117	0.00117	CcSEcCtD
